Inhibition of Fibroblast Activation Protein-α Ameliorates Intervertebral Disc Degeneration via Reduced Vascular Invasion in Cartilage Endplate

Abstract

Intervertebral disc degeneration (IDD) is a primary cause of low back pain, with the development of new blood vessels being a key pathological feature. Fibroblast activation protein-alpha (FAP-α), a member of the Type II serine protease family, possesses dipeptidase and collagenase activities and is closely linked to angiogenesis. Bioinformatics and immunohistochemical analysis revealed elevated FAP-α expression and increased angiogenesis in degenerated cartilage endplate (CEP). Co-culture of FAP-α-silenced CEP cells or conditioned media with human umbilical vein endothelial cells (HUVECs) demonstrated a reduction in hypoxia-inducible factor-α (HIF-α) levels, vascular endothelial growth factor (VEGF)-A and PI3K/AKT phosphorylation, which impaired HUVEC migration and tube formation. Conversely, FAP-α overexpression enhanced angiogenesis via the PI3K/AKT/HIF-α/VEGF-A signalling pathway. In rats with IDD induced by lumbar instability, FAP-α inhibitors reduced angiogenesis and ossification of the CEP, thereby delaying IDD progression associated with CEP degeneration. Genetic deletion of FAP further slowed IDD progression. Collectively, these findings provide compelling evidence that FAP-α accelerates IDD by promoting angiogenesis, which disrupts disc homeostasis. Targeting FAP-α may offer a novel therapeutic approach for mitigating IDD.

Keywords

angiogenesis / cartilage endplate / fibroblast activation protein-α / intervertebral disc degeneration / PI3K/Akt/HIF-1α/VEGFA pathway

References

[1] N. N. Knezevic, K. D. Candido, J. W. S. Vlaeyen, J. Van Zundert, and S. P. Cohen, “Low Back Pain,” Lancet 398, no. 10294 (2021): 78–92.

[2] S. Kirnaz, C. Capadona, T. Wong, et al., “Fundamentals of Intervertebral Disc Degeneration,” World Neurosurgery 157 (2022): 264–273.

[3] C. R. Hassan, W. Lee, D. E. Komatsu, and Y. X. Qin, “Evaluation of Nucleus Pulposus Fluid Velocity and Pressure Alteration Induced by Cartilage Endplate Sclerosis Using a Poro-Elastic Finite Element Analysis,” Biomechanics and Modeling in Mechanobiology 20, no. 1 (2021): 281–291.

[4] E. J. Novais, R. Narayanan, J. A. Canseco, et al., “A New Perspective on Intervertebral Disc Calcification-From Bench to Bedside,” Bone Research 12, no. 1 (2024): 3.

[5] H. Xu, J. Li, Q. Fei, and L. Jiang, “Contribution of Immune Cells to Intervertebral Disc Degeneration and the Potential of Immunotherapy,” Connective Tissue Research 64, no. 5 (2023): 413–427.

[6] M. A. Abd El-Azeem, M. A. Ali, and S. H. El-Shorbagy, “Expression of GLUT4 and FAP in Urothelial Bladder Carcinoma: Correlation With Angiogenesis and Clinicopathological Characteristics,” Journal of the Egyptian National Cancer Institute 34, no. 1 (2022): 40.

[7] W. Qi, L. Jin, C. Wu, et al., “Treatment With FAP-Targeted Zinc Ferrite Nanoparticles for Rheumatoid Arthritis by Inducing Endoplasmic Reticulum Stress and Mitochondrial Damage,” Materials Today Bio 21 (2023): 100702.

[8] X. Zhao, J. Lin, M. Liu, et al., “Targeting FAP-Positive Chondrocytes in Osteoarthritis: A Novel Lipid Nanoparticle siRNA Approach to Mitigate Cartilage Degeneration,” Journal of Nanobiotechnology 22, no. 1 (2024): 659.

[9] Z. Zhang, Q. Gan, J. Han, Q. Tao, W. Q. Qiu, and J. A. Madri, “CD31 as a Probable Responding and Gate-Keeping Protein of the Blood-Brain Barrier and the Risk of Alzheimer's Disease,” Journal of Cerebral Blood Flow and Metabolism 43, no. 7 (2023): 1027–1041.

[10] J. H. Song, B. Hwang, S. Lyea Park, et al., “IL-28A/IL-10Rβ Axis Promotes Angiogenesis via eNOS/AKT Signaling and AP-1/NF-κB/MMP-2 Network by Regulating HSP70-1 Expression,” Journal of Advanced Research 73 (2025): 247–263.

[11] S. J. Chang, X. W. Zhang, H. W. Xu, et al., “CeO(2) Nanoparticles Reduce Oxidative Stress and Delay the Degeneration of Intervertebral Disc,” Bioinorganic Chemistry and Applications 2025 (2025): 3399767.

[12] Y. Li, T. Zhang, W. Tian, et al., “Loss of TIMP3 Expression Induces Inflammation, Matrix Degradation, and Vascular Ingrowth in Nucleus Pulposus: A New Mechanism of Intervertebral Disc Degeneration,” FASEB Journal 34, no. 4 (2020): 5483–5498.

[13] Y. Wang, M. Che, J. Xin, Z. Zheng, J. Li, and S. Zhang, “The Role of IL-1β and TNF-α in Intervertebral Disc Degeneration,” Biomedicine & Pharmacotherapy 131 (2020): 110660.

[14] Z. R. Schoepflin, E. S. Silagi, I. M. Shapiro, and M. V. Risbud, “PHD3 Is a Transcriptional Coactivator of HIF-1α in Nucleus Pulposus Cells Independent of the PKM2-JMJD5 Axis,” FASEB Journal 31, no. 9 (2017): 3831–3847.

[15] R. He, Z. Wang, M. Cui, et al., “HIF1A Alleviates Compression-Induced Apoptosis of Nucleus Pulposus Derived Stem Cells via Upregulating Autophagy,” Autophagy 17, no. 11 (2021): 3338–3360.

[16] Z. Wang, H. Chen, Q. Tan, et al., “Inhibition of Aberrant Hif1α Activation Delays Intervertebral Disc Degeneration in Adult Mice,” Bone Research 10, no. 1 (2022): 2.

[17] H. J. Harris, P. Łaniewski, H. Cui, D. J. Roe, D. M. Chase, and M. M. Herbst-Kralovetz, “Cervicovaginal Lavages Uncover Growth Factors as Key Biomarkers for Early Diagnosis and Prognosis of Endometrial Cancer,” Molecular Biomedicine 5, no. 1 (2024): 55.

[18] F. Cao, S. Wang, H. Wang, and W. Tang, “Fibroblast Activation Protein-α in Tumor Cells Promotes Colorectal Cancer Angiogenesis via the Akt and ERK Signaling Pathways,” Molecular Medicine Reports 17, no. 2 (2018): 2593–2599.

[19] C. Zeng, M. Wen, and X. Liu, “Fibroblast Activation Protein in Osteosarcoma Cells Promotes Angiogenesis via AKT and ERK Signaling Pathways,” Oncology Letters 15, no. 4 (2018): 6029–6035.

[20] Y. Huang, H. Li, L. Qi, et al., “NanoCRISPR-Assisted Biomimetic Tissue-Equivalent Patch Regenerates the Intervertebral Disc by Inhibiting Endothelial-To-Mesenchymal Transition,” Biomaterials 322 (2025): 123404.

[21] H. Zheng, J. Yu, L. Gao, et al., “S1PR1-Biased Activation Drives the Resolution of Endothelial Dysfunction-Associated Inflammatory Diseases by Maintaining Endothelial Integrity,” Nature Communications 16, no. 1 (2025): 1826.

[22] N. Alfaidy, P. Hoffmann, H. Boufettal, et al., “The Multiple Roles of EG-VEGF/PROK1 in Normal and Pathological Placental Angiogenesis,” BioMed Research International 2014 (2014): 451906.

[23] M. He, J. Pang, H. Sun, G. Zheng, Y. Lin, and W. Ge, “P14ARF Inhibits Regional Inflammation and Vascularization in Intervertebral Disc Degeneration by Upregulating TIMP3,” American Journal of Physiology. Cell Physiology 318, no. 4 (2020): C751–c761.

[24] H. J. Moon, T. Yurube, T. P. Lozito, et al., “Effects of Secreted Factors in Culture Medium of Annulus Fibrosus Cells on Microvascular Endothelial Cells: Elucidating the Possible Pathomechanisms of Matrix Degradation and Nerve in-Growth in Disc Degeneration,” Osteoarthritis and Cartilage 22, no. 2 (2014): 344–354.

[25] S. Payne, A. Neal, and S. De Val, “Transcription Factors Regulating Vasculogenesis and Angiogenesis,” Developmental Dynamics 253, no. 1 (2024): 28–58.

[26] S. Goel, D. G. Duda, L. Xu, et al., “Normalization of the Vasculature for Treatment of Cancer and Other Diseases,” Physiological Reviews 91, no. 3 (2011): 1071–1121.

[27] X. Bao, J. Zhang, G. Huang, et al., “The Crosstalk Between HIFs and Mitochondrial Dysfunctions in Cancer Development,” Cell Death & Disease 12, no. 2 (2021): 215.

[28] M. H. Fan, Q. Zhu, H. H. Li, et al., “Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance From Lungs in Mice,” Journal of Biological Chemistry 291, no. 15 (2016): 8070–8089.

[29] F. Liu, S. Chao, L. Yang, et al., “Molecular Mechanism of Mechanical Pressure Induced Changes in the Microenvironment of Intervertebral Disc Degeneration,” Inflammation Research 73, no. 12 (2024): 2153–2164.

[30] J. M. Robbins, P. Rao, S. Deng, et al., “Plasma Proteomic Changes in Response to Exercise Training Are Associated With Cardiorespiratory Fitness Adaptations,” JCI Insight 8, no. 7 (2023): e165867.

[31] A. J. Lay, H. E. Zhang, G. W. McCaughan, and M. D. Gorrell, “Fibroblast Activation Protein in Liver Fibrosis,” Front Biosci (Landmark Ed) 24, no. 1 (2019): 1–17.

[32] J. Cai, D. Yang, H. Sun, et al., “A Multifactorial Analysis of FAP to Regulate Gastrointestinal Cancers Progression,” Frontiers in Immunology 14 (2023): 1183440.

[33] A. Steplewski, H. Ito, E. Rucker, et al., “Position of Single Amino Acid Substitutions in the Collagen Triple Helix Determines Their Effect on Structure of Collagen Fibrils,” Journal of Structural Biology 148, no. 3 (2004): 326–337.

[34] A. Fan, G. Wu, J. Wang, et al., “Inhibition of Fibroblast Activation Protein Ameliorates Cartilage Matrix Degradation and Osteoarthritis Progression,” Bone Research 11, no. 1 (2023): 3.

[35] H. Swahn, K. Li, T. Duffy, et al., “Senescent Cell Population With ZEB1 Transcription Factor as Its Main Regulator Promotes Osteoarthritis in Cartilage and Meniscus,” Annals of the Rheumatic Diseases 82, no. 3 (2023): 403–415.

[36] R. Bughda, P. Dimou, R. R. D'Souza, and A. Klampatsa, “Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma,” ImmunoTargets and Therapy 10 (2021): 313–323.

[37] J. Guan, H. Zhang, Z. Wen, et al., “Retinoic Acid Inhibits Pancreatic Cancer Cell Migration and EMT Through the Downregulation of IL-6 in Cancer Associated Fibroblast Cells,” Cancer Letters 345, no. 1 (2014): 132–139.

[38] Y. Gan, J. He, J. Zhu, et al., “Spatially Defined Single-Cell Transcriptional Profiling Characterizes Diverse Chondrocyte Subtypes and Nucleus Pulposus Progenitors in Human Intervertebral Discs,” Bone Research 9, no. 1 (2021): 37.

[39] C. W. Pfirrmann, A. Metzdorf, M. Zanetti, J. Hodler, and N. Boos, “Magnetic Resonance Classification of Lumbar Intervertebral Disc Degeneration,” Spine (Phila Pa 1976) 26, no. 17 (2001): 1873–1878.

[40] M. A. Sánchez-Garrido, K. M. Habegger, C. Clemmensen, et al., “Fibroblast Activation Protein (FAP) as a Novel Metabolic Target,” Molecular Metabolism 5, no. 10 (2016): 1015–1024.

[41] S. Liu, Y. Sun, J. Dong, and Q. Bian, “A Mouse Model of Lumbar Spine Instability,” Journal of Visualized Experiments 170 (2021): e61722.

[42] H. W. Xu, X. Y. Fang, X. W. Liu, et al., “α-Ketoglutaric Acid Ameliorates Intervertebral Disk Degeneration by Blocking the IL-6/JAK2/STAT3 Pathway,” American Journal of Physiology Cell Physiology 325, no. 4 (2023): C1119–c1130.

[43] S. J. Chang, H. W. Xu, S. B. Zhang, X. W. Liu, Y. Y. Yi, and S. J. Wang, “Excessive Cholesterol Accelerates Intervertebral Disc Degeneration by Promoting the Polarization of M1 Macrophages,” Lipids in Health and Disease 24, no. 1 (2025): 305.

[44] C. Y. Chen, S. S. Rao, L. Ren, et al., “Exosomal DMBT1 From Human Urine-Derived Stem Cells Facilitates Diabetic Wound Repair by Promoting Angiogenesis,” Theranostics 8, no. 6 (2018): 1607–1623.

[45] X. Li, X. Xie, W. Lian, et al., “Exosomes From Adipose-Derived Stem Cells Overexpressing Nrf2 Accelerate Cutaneous Wound Healing by Promoting Vascularization in a Diabetic Foot Ulcer Rat Model,” Experimental & Molecular Medicine 50, no. 4 (2018): 1–14.

RIGHTS & PERMISSIONS

2026 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.